Mesenchymal stem cell-mediated suppression of hypertrophic scarring is p53 dependent in a rabbit ear model

Stem Cell Research and Therapy

Volumn 5, Issue 6, 2014, Pages

  Liu, Yi Lun ^a   Liu, Wei Hua ^a   Sun, Jin ^a   Hou, Tuan Jie ^b   Liu, Yue Ming ^a   Liu, Hai Rong ^a   Luo, Yong Hui ^a   Zhao, Ning Ning ^a   Tang, Ying ^a   Deng, Feng Mei ^a  

^a CHENGDU MEDICAL COLLEGE   (China)

^b NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; MESSENGER RNA; NITRIC OXIDE; PROTEIN P53; SHORT HAIRPIN RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CUTANEOUS PARAMETERS; DISEASE COURSE; DOWN REGULATION; ENGRAFTMENT; FIBROBLAST; FROZEN SECTION; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; HYPERTROPHIC SCAR; INFANT; MALE; MESENCHYMAL STEM CELL; MYOFIBROBLAST; NEW ZEALAND WHITE (RABBIT); NONHUMAN; P53 GENE; PARACRINE SIGNALING; PRIORITY JOURNAL; SCAR ELEVATION INDEX; STAINING; ANIMAL; CELL CULTURE; CICATRIX; CYTOLOGY; EAR; GENETICS; INJURIES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; RABBIT; SKIN;

ORYCTOLAGUS CUNICULUS;

ANIMALS; CELLS, CULTURED; CICATRIX; EAR; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RABBITS; SKIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84927944378     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt526     Document Type: Article

References (43)

1. Viera MH, Amini S, Valins W, Berman B: Innovative therapies in the treatment of keloids and hypertrophic scars. J Clin Aesthet Dermatol 2010, 3:20-26.
2. Bloemen MC, van der Veer WM, Ulrich MM, van Zuijlen PP, Niessen FB, Middelkoop E: Prevention and curative management of hypertrophic scar formation. Burns 2009, 35:463-475.
3. Gabriel V: Hypertrophic scar. Phys Med Rehabil Clin N Am 2011, 22: 301-310.
4. Ding J, Ma Z, Shankowsky HA, Medina A, Tredget EE: Deep dermal fibroblast profibrotic characteristics are enhanced by bone marrowderived mesenchymal stem cells. Wound Repair Regen 2013, 21:448-455.
5. Wu Y, Wang J, Scott PG, Tredget EE: Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen 2007, 15:S18-S26.
6. Uccelli A, Moretta L, Pistoia V: Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008, 8:726-736.
7. Bergfeld SA, DeClerck YA: Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev 2010, 29:249-261.
8. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M: Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002, 62:3603-3608.
9. Chen JS, Wong VW, Gurtner GC: Therapeutic potential of bone marrowderived mesenchymal stem cells for cutaneous wound healing. Front Immunol 2012, 3:192.
10. Singer NG, Caplan AI: Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 2011, 6:457-478.
11. Lam MT, Nauta A, Meyer NP, Wu JC, Longaker MT: Effective delivery of stem cells using an extracellular matrix patch results in increased cell survival and proliferation and reduced scarring in skin wound healing. Tissue Eng Part A 2013, 19:738-747.
12. Huang Y, Yu P, Li W, Ren G, Roberts AI, Cao W, Zhang X, Su J, Chen X, Chen Q, Shou P, Xu C, Du L, Lin L, Xie N, Zhang L, Wang Y, Shi Y: p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation. Oncogene 2013, 33:3830-3838.
13. Ennis WJ, Sui A, Bartholomew A: Stem cells and healing: impact on inflammation. Adv Wound Care (New Rochelle) 2013, 2:369-378.
14. Li W, Ren G, Huang Y, Su J, Han Y, Li J, Chen X, Cao K, Chen Q, Shou P, Zhang L, Yuan ZR, Roberts AI, Shi S, Le AD, Shi Y: Mesenchymal stem cells: a double-edged sword in regulating immune responses. Cell Death Differ 2012, 19:1505-1513.
15. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y: Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008, 2:141-150.
16. Penn JW, Grobbelaar AO, Rolfe KJ: The role of the TGF-beta family in wound healing, burns and scarring: a review. Int J Burns Trauma 2012, 2:18-28.
17. De Felice B, Garbi C, Santoriello M, Santillo A, Wilson RR: Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts. Mol Cell Biochem 2009, 327:191-201.
18. Tanaka A, Hatoko M, Tada H, Iioka H, Niitsuma K, Miyagawa S: Expression of p53 family in scars. J Dermatol Sci 2004, 34:17-24.
19. Moon JH, Kwak SS, Park G, Jung HY, Yoon BS, Park J, Ryu KS, Choi SC, Maeng I, Kim B, Jun EK, Kim S, Kim A, Oh S, Kim H, Kim KD, You S: Isolation and characterization of multiipotent human keloid-derived mesenchymal-like stem cells. Stem Cells Dev 2008, 17:713-724.
20. Kryger ZB, Sisco M, Roy NK, Lu L, Rosenberg D, Mustoe TA: Temporal expression of the transforming growth factor-Beta pathway in the rabbit ear model of wound healing and scarring. J Am Coll Surg 2007, 205:78-88.
21. Liang Q, Liu S, Han P, Li X, Li X, Zhao Y, Liang Y, Deng Z, Jin Y: Micronized acellular dermal matrix as an efficient expansion substrate and delivery vehicle of adipose-derived stem cells for vocal fold regeneration. Laryngoscope 2012, 122:1815-1825.
22. Kloeters O, Tandara A, Mustoe TA: Hypertrophic scar model in the rabbit ear: a reproducible model for studying scar tissue behavior with new observations on silicone gel sheeting for scar reduction. Wound Repair Regen 2007, 15:S40-S45.
23. Miranda KM, Espey MG, Wink DA: A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001, 5:62-71.
24. Ruan GP, Han YB, Wang TH, Xing ZG, Zhu XB, Yao X, Ruan GH, Wang JX, Pang RQ, Cai XM, He J, Zhao J, Pan XH: Comparative study among three different methods of bone marrow mesenchymal stem cell transplantation following cerebral infarction in rats. Neurol Res 2013, 35:212-220.
25. Wipff PJ, Hinz B: Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. Eur J Cell Biol 2008, 87:601-615.
26. Forrester K, Ambs S, Lupold SE, Kapust RB, Spillare EA, Weinberg WC, Felley-Bosco E, Wang XW, Geller DA, Tzeng E, Billiar TR, Harris CC: Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci U S A 1996, 93:2442-2447.
27. Cubison TC, Pape SA, Parkhouse N: Evidence for the link between healing time and the development of hypertrophic scars (HTS) in paediatric burns due to scald injury. Burns 2006, 32:992-999.
28. Liu S, Jiang L, Li H, Shi H, Luo H, Zhang Y, Yu C, Jin Y: Mesenchymal stem cells prevent hypertrophic scar formation via inflammatory regulation when undergoing apoptosis. J Invest Dermatol 2014, 134:2648-2657.
29. Lewis WH, Sun KK: Hypertrophic scar: a genetic hypothesis. Burns 1990, 16:176-178.
30. Thompson CM, Hocking AM, Honari S, Muffley LA, Ga M, Gibran NS: Genetic risk factors for hypertrophic scar development. J Burn Care Res 2013, 34:477-482.
31. Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW: Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg 2003, 111:535-543. discussion 544-546.
32. Mandel K, Yang Y, Schambach A, Glage S, Otte A, Hass R: Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo. Stem Cells Dev 2013, 22:3114-3127.
33. Ryu HS, do Park J, Kim HH, Kim WH, Lee HS: Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer. Hum Pathol 2012, 43:520-528.
34. Wang H, Zhang G, Zhang H, Zhang F, Zhou B, Ning F, Wang HS, Cai SH, Du J: Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/beta-catenin/Snail signaling pathway. Eur J Pharmacol 2014, 723:156-166.
35. Strassburg S, Hodson NW, Hill PI, Richardson SM, Hoyland JA: Bi-directional exchange of membrane components occurs during co-culture of mesenchymal stem cells and nucleus pulposus cells. PLoS One 2012, 7:e33739.
36. Ennis WJ, Meneses P: Wound healing at the local level: the stunned wound. Ostomy Wound Manage 2000, 46: 39S-48S. quiz 49S-50S.
37. Wynn TA: Cellular and molecular mechanisms of fibrosis. J Pathol 2008, 214:199-210.
38. Guo W, Shan B, Klingsberg RC, Qin X, Lasky JA: Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. Am J Physiol Lung Cell Mol Physiol 2009, 297:L864-L870.
39. Garrett Q, Khaw PT, Blalock TD, Schultz GS, Grotendorst GR, Daniels JT: Involvement of CTGF in TGF-beta1-stimulation of myofibroblast differentiation and collagen matrix contraction in the presence of mechanical stress. Invest Ophthalmol Vis Sci 2004, 45:1109-1116.
40. Kurz T, Gustafsson B, Brunk UT: Intralysosomal iron chelation protects against oxidative stress-induced cellular damage. FEBS J 2006, 273:3106-3117.
41. Radosavljevic T, Mladenovic D, Vucevic D, Vukicevic RJ: The role of oxidative/nitrosative stress in pathogenesis of paracetamol-induced toxic hepatitis. Med Pregl 2010, 63:827-832.
42. Svegliati Baroni G, D'Ambrosio L, Ferretti G, Casini A, Di Sario A, Salzano R, Ridolfi F, Saccomanno S, Jezequel AM, Benedetti A: Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 1998, 27:720-726.
43. Liu YL, Liu YM, Sun J, Wen K: Significance of glutathione and coenzyme II in pathological scars. Zhongguo Mei Rong Zheng Xing Wai Ke Za Zhi 2009, 20:501-503.